Pharmaceutical, biotechnology, and medical device manufacturing firms are facing legislative uncertainty, mounting regulatory pressure, volatile economic conditions. It is for these reasons that more firms in this space are automating their Procure-to-Pay (P2P) processes.
Eliminating friction in the P2P cycle with technologies such as electronic invoicing helps pharmaceutical, biotechnology, and medical device manufacturing firms:
• Improve profit margins
• Enhance visibility into cash flow
• Lower their cost of goods
Best of all: P2P automation delivers these benefits, regardless of the legislative, regulatory and business conditions.